bioMérieux Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Pierre Boulud

Geschäftsführender

€2.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts25.7%
Amtszeit als Geschäftsführer1.3yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements3.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder9.9yrs

Jüngste Management Updates

Recent updates

bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing

Sep 26
bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing

bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

Sep 08
bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

Return Trends At bioMérieux (EPA:BIM) Aren't Appealing

Aug 03
Return Trends At bioMérieux (EPA:BIM) Aren't Appealing

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

May 30
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)

Apr 18
Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)

bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings

Mar 31
bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings

bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 17
bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Mar 15
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Jan 27
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

Jan 06
bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 16
A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Oct 23
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

Oct 05
bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Sep 15
There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Jun 30
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Jun 09
Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Mar 31
Is bioMérieux (EPA:BIM) Using Too Much Debt?

The Return Trends At bioMérieux (EPA:BIM) Look Promising

Feb 23
The Return Trends At bioMérieux (EPA:BIM) Look Promising

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jan 27
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

Dec 16
bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Oct 18
bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Sep 14
Is bioMérieux (EPA:BIM) Using Too Much Debt?

Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

Aug 11
Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Jul 23
An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jul 05
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

May 26
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

May 11
Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

Apr 23
bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

Apr 09
bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Mar 25
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Mar 13
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Feb 08
I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Why We Like The Returns At bioMérieux (EPA:BIM)

Dec 21
Why We Like The Returns At bioMérieux (EPA:BIM)

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 07
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Nov 07
Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Is bioMérieux (EPA:BIM) A Risky Investment?

Oct 07
Is bioMérieux (EPA:BIM) A Risky Investment?

Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Sep 22
Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Aug 06
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

Jun 15
There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

May 31
A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Apr 30
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

bioMérieux (EPA:BIM) Could Easily Take On More Debt

Mar 28
bioMérieux (EPA:BIM) Could Easily Take On More Debt

The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Mar 13
The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Feb 25
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

Feb 09
If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Jan 20
If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

Dec 30
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?

Dec 03
Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Pierre Boulud im Vergleich zu den Einnahmen von bioMérieux verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

€411m

Mar 31 2024n/an/a

€384m

Dec 31 2023€2m€631k

€358m

Sep 30 2023n/an/a

€372m

Jun 30 2023n/an/a

€386m

Mar 31 2023n/an/a

€419m

Dec 31 2022€2m€510k

€452m

Sep 30 2022n/an/a

€502m

Jun 30 2022n/an/a

€552m

Mar 31 2022n/an/a

€577m

Dec 31 2021€2m€510k

€601m

Sep 30 2021n/an/a

€555m

Jun 30 2021n/an/a

€509m

Mar 31 2021n/an/a

€457m

Dec 31 2020€1m€497k

€404m

Vergütung im Vergleich zum Markt: PierreDie Gesamtvergütung ($USD2.64M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt French ($USD4.76M).

Entschädigung vs. Einkommen: PierreDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.


Geschäftsführer

Pierre Boulud (53 yo)

1.3yrs

Amtszeit

€2,452,864

Vergütung

Mr. Pierre Boulud is Chief Executive Officer of bioMérieux S.A. from July 01, 2023. He served as Chief Operating Officer of Clinical Operations at BioMérieux S.A. until 2023 and served as its Chief Operati...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Pierre Boulud
Chief Executive Officer1.3yrs€2.45mkeine Daten
Guillaume Bouhours
Executive VP of Purchasing and Information Systems & CFO6.6yrskeine Datenkeine Daten
Sylvain Morgeau
Investor Relationsno datakeine Datenkeine Daten
Audrey Dauvet
Executive Vice President of Legal1.8yrskeine Datenkeine Daten
Valerie Leylde
Executive Vice President of Human Resources5.8yrskeine Datenkeine Daten
Pierre Charbonnier
Executive Vice President of Global Quality6.6yrskeine Datenkeine Daten
Yasha Mitrotti
Executive Vice President of Industrial Applications6.6yrskeine Datenkeine Daten
Frederic Beseme
Head of CSR4.8yrs€21.99kkeine Daten
Jennifer Zinn
Executive Vice President of Clinical Operations1.2yrskeine Datenkeine Daten
Charles Cooper
Executive VP & Chief Medical Officerless than a yearkeine Datenkeine Daten
Celine Roger-Dalbert
Executive Vice President of Research & Developmentless than a yearkeine Datenkeine Daten
Franck Admant
Director of Investor Relationsno datakeine Datenkeine Daten

3.3yrs

Durchschnittliche Betriebszugehörigkeit

51.5yo

Durchschnittliches Alter

Erfahrenes Management: BIMDas Führungsteam des Unternehmens gilt als erfahren (2.9 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Alain Merieux
Founding Chairman7.2yrskeine Datenkeine Daten
Jean-Luc Belingard
Non-Independent Director18.1yrs€52.00k0.051%
€ 6.5m
Philippe Archinard
Non-Independent Director14.3yrs€61.00k0.000030%
€ 3.8k
Alexandre Merieux
Chairman20.5yrs€1.92m0.000050%
€ 6.3k
Harold Y. Boel
Independent Director12.4yrs€56.00k0.00013%
€ 16.5k
Marie-Helene Habert-Dassault
Independent Director12.4yrs€44.00k0.000050%
€ 6.3k
Fanny Letier
Independent Director7.4yrs€61.17k0.000030%
€ 3.8k
Viviane Monges
Independent Directorless than a yearkeine Datenkeine Daten
Marie-Paule Kieny
Independent Director7.2yrs€35.00k0.00015%
€ 19.0k
Sylvain Orenga
Employee Representative Director2.4yrs€52.00kkeine Daten

9.9yrs

Durchschnittliche Betriebszugehörigkeit

60.5yo

Durchschnittliches Alter

Erfahrener Vorstand: BIMDie Vorstandsmitglieder gelten als erfahren (9.6 Jahre durchschnittliche Amtszeit).